Invesco Ltd. V Tv Therapeutics Inc. Call Options Transaction History
Invesco Ltd.
- $499 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VTVT
# of Institutions
1Shares Held
243KCall Options Held
0Put Options Held
0About vTv Therapeutics Inc.
- Ticker VTVT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 81,483,600
- Market Cap $1.42B
- Description
- vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...